Marijuana stocks are on a tear, thanks in part to Canada’s move to legalize the substance
The ETFMG Alternative Harvest exchange-traded fund, which invests in some of the most notable medicinal-marijuana companies and holds stocks such as cannabis producers Cronos Group Inc., Canopy Growth Corp.
and Aurora Cannabis Inc., has soared 44% in 2019.Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Canadian provinces vow to resist Trudeau's landmark carbon taxCanada on Monday imposed a landmark carbon tax on four provinces which had defie...
Consulte Mais informação »
Skilled, foreign workers are giving up on their American dreams — and turning to CanadaTens of thousands of foreign workers are rushing to file their H-1B visa applications by April 1. Many will be rejected, and some will turn to Canada.
Consulte Mais informação »
Rolling Stones delay tour as Jagger seeks medical treatmentThe Rolling Stones have postponed a tour of the United States and Canada to give...
Consulte Mais informação »
Canada tribunal recommends tariffs for two types of steel, exclusion for othersThe Canadian International Trade Tribunal (CITT) said on Wednesday that tariffs ...
Consulte Mais informação »
Canada says reopening USMCA trade pact could be a 'Pandora's box'Canadian Foreign Minister Chrystia Freeland on Thursday cautioned against the id...
Consulte Mais informação »
Air Canada delays launch of seasonal routes due to Boeing MAX groundingAir Canada said on Tuesday it would delay the launch of certain seasonal flights...
Consulte Mais informação »
Canada says third canola exporter has run into trouble in ChinaChinese authorities have filed a quality complaint against a third Canadian expo...
Consulte Mais informação »
Canada auto sales fall 2.5 percent in MarchCanada's auto sales fell 2.5 percent in March from a year earlier, marking ...
Consulte Mais informação »
Pelosi demands changes to Trump’s trade deal with Mexico, CanadaDelay risks complicating uphill path to approval
Consulte Mais informação »